Article info
Original research
Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study
- Correspondence to Dr Alice Bergamini, Department of Obstetrics and Gynecology, IRCCS Ospedale San Raffaele, Milano 20132, Italy; bergamini.alice{at}hsr.it
Citation
Surveillance alone in stage I malignant ovarian germ cell tumors: a MITO (Multicenter Italian Trials in Ovarian cancer) prospective observational study
Publication history
- Received February 28, 2021
- Revision received May 1, 2021
- Accepted May 5, 2021
- First published May 25, 2021.
Article Versions
- You are currently viewing a Previous version of this article (8 January 2022).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.